Second, since the level of SHBG was not measured in our patients, we could not evaluate the role of free and bioavailable testosterone in the risk of developing NAFLD in patients with T2DM. The gene discussed is SHBG; the disease is metabolic dysfunction-associated steatotic liver disease.